A study to investigate the safety, tolerability, and pharmacokinetics of Ent001 in patients with moderately to severely active ulcerative colitis

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507340-36-00

Acronym

Ent001-CL-102

Enrollment

Registered

2024-03-18

Start date

2024-04-22

Completion date

2025-05-14

Last updated

2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel disease (moderate to severe active ulcerative colitis)

None listed

Sex/Gender

All

Age

18 Years to No maximum

Bulgaria, Hungary, Netherlands, Romania

None listed

Source: EU CTIS · Data processed: Feb 4, 2026